化合物 T14993 T14993
品牌 | 厂商性质 | 产地 | 货期 |
---|---|---|---|
TargetMol | 生产商 | 美国 | 现货 |
性能特点
生化试剂,可用于动物细胞实验
规格 | CAS号 | 价格 | 操作 |
---|---|---|---|
5 mg | 1446700-26-0 | ¥413.00 | 询底价 |
25 mg | 1446700-26-0 | ¥1,130.00 | 询底价 |
2 mg | 1446700-26-0 | ¥252.00 | 询底价 |
10 mg | 1446700-26-0 | ¥663.00 | 询底价 |
1 mL | 1446700-26-0 | ¥578.00 | 询底价 |
Product Introduction
Bioactivity
英文名: Rociletinib hydrobromide
描述: Rociletinib hydrobromide is an orally delivered inhibitor of the mutant form of EGFR kinase (Kis: 21.5 nM and 303.3 nM for EGFR L858R/T790M and EGFR WT).
体外活性: Rociletinib resistant NSCLC cell lines are sensitive to AKT inhibition. Rociletinib selectively inhibits the growth of NSCLC cells expressing mutant EGFR and induces apoptosis. Rociletinib (0.1 μM) inhibits EGFR potently and irreversibly. It inhibits more than 50% of 23 targets.
体内活性: Rociletinib (50 mg/kg bid, p.o.) shows anti-tumor activity in human EGFR-L858R and EGFR-L858R-T790M expressing transgenic mice. Rociletinib (100 mg/kg/day, p.o.) displays anti-tumor activity in NSCLC EGFR mutant xenograft models.
存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year
溶解度: DMSO : 59 mg/mL (92.70 mM)
关键字: AVL-301 Hydrobromide | CNX 419 Hydrobromide | CO 1686 | AVL301 Hydrobromide | CO-1686 | Rociletinib hydrobromide | CNX-419 Hydrobromide | Rociletinib Hydrobromide | CO1686 | CNX419 Hydrobromide | AVL 301 Hydrobromide
化合物 T14993 T14993信息由TargetMol中国为您提供,如您想了解更多关于化合物 T14993 T14993报价、型号、参数等信息,欢迎来电或留言咨询。
注:该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案,不可用于临床诊断或治疗等相关用途